Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis

Nature Communications

Volumn 5, Issue , 2014, Pages

  Sugihara, K ^a   Kobayashi, Y ^b   Suzuki, A ^c   Tamura, N ^b   Motamedchaboki, K ^b   Huang, C T ^b   Akama, T O ^b   Pecotte, J ^d   Frost, P ^d   Bauer, C ^d   Jimenez, J B ^d   Nakayama, J ^e   Aoki, D ^c   Fukuda, M N ^d  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BURNHAM INSTITUTE   (United States)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^e SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC NUCLEOTIDE; PEPTIDE; PROAPOPTOTIC PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; Z13 RECEPTOR; CNGB3 PROTEIN, HUMAN; CYCLIC NUCLEOTIDE GATED CHANNEL; DNA BINDING PROTEIN; PEPTIDE LIBRARY; ZNF473 PROTEIN, HUMAN;

APOPTOSIS; CELLS AND CELL COMPONENTS; CONTRACEPTIVE USE; DISEASE CONTROL; DRUG; INFERTILITY; LESION; PEPTIDE; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BABOON; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; ENDOMETRIAL EPITHELIAL CELL; ENDOMETRIOSIS; ENDOMETRIUM; ENDOSOME; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOUSE; NONHUMAN; PERITONEUM; PHAGE DISPLAY; PROTEOMICS; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MOLECULAR GENETICS; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PEPTIDE LIBRARY; PERITONEAL DISEASES; PRECLINICAL STUDY; PROCEDURES;

PAPIO;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DRUG EVALUATION, PRECLINICAL; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; HUMANS; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; PAPIO; PEPTIDE LIBRARY; PEPTIDES; PERITONEAL DISEASES;

EID: 84928761756     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5478     Document Type: Article

References (41)

1. Sensky, T. E. & Liu, D. T. Endometriosis: associations with menorrhagia, infertility and oral contraceptives. Int. J. Gynaecol. Obstet. 17, 573-576 (1980).
2. Houston, D. E. Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status. Epidemiol. Rev. 6, 167-191 (1984).
3. Murphy, A. A. Clinical aspects of endometriosis. Ann. NY Acad. Sci. 955, 1-10 discussion 34-16, 396-406 (2002).
4. Farquhar, C. M. Extracts from the 'clinical evidence'. Endometriosis. BMJ 320, 1449-1452 (2000).
5. D'Hooghe, T. M. Clinical relevance of the baboon as a model for the study of endometriosis. Fertil. Steril. 68, 613-625 (1997).
6. Rier, S. E., Martin, D. C., Bowman, R. E., Dmowski, W. P. & Becker, J. L. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2, 3, 7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 21, 433-441 (1993).
7. Rier, S. E. et al. Serum levels of TCDD and dioxin-like chemicals in Rhesus monkeys chronically exposed to dioxin: correlation of increased serum PCB levels with endometriosis. Toxicol. Sci. 59, 147-159 (2001).
8. Giudice, L. C. & Kao, L. C. Endometriosis. Lancet 364, 1789-1799 (2004).
9. Osteen, K. G. & Sierra-Rivera, E. Does disruption of immune and endocrine systems by environmental toxins contribute to development of endometriosis? Semin. Reprod. Endocrinol. 15, 301-308 (1997).
10. Hayes, E. C. & Rock, J. A. COX-2 inhibitors and their role in gynecology. Obstet. Gynecol. Surv. 57, 768-780 (2002).
11. Olive, D. L. & Pritts, E. A. Treatment of endometriosis. New Engl. J. Med. 345, 266-275 (2001).
12. Amsterdam, L. L. et al. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil. Steril. 84, 300-304 (2005).
13. Johnson, N. & Farquhar, C. Endometriosis. Clin. Evid. 15, 2449-2464 (2006).
14. Vercellini, P. et al. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil. Steril. 80, 560-563 (2003).
15. Vercellini, P. et al. Repetitive surgery for recurrent symptomatic endometriosis: what to do? Eur. J. Obstet. Gynecol. Reprod. Biol. 146, 15-21 (2009).
16. Vinatier, D., Orazi, G., Cosson, M. & Dufour, P. Theories of endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 96, 21-34 (2001).
17. Shampson, J. A. The development of the implantation theory for the origin of peritoneal endometriosis. Am. J. Obstet. Gynecol. 40, 549-557 (1940).
18. Zhang, J., Spring, H. & Schwab, M. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. Cancer Lett. 171, 153-164 (2001).
19. Eisenhardt, S. U., Schwarz, M., Bassler, N. & Peter, K. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Nat. Protoc. 2, 3063-3073 (2007).
20. Lessey, B. A. et al. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin. J. Steroid Biochem. Mol. Biol. 59, 31-39 (1996).
21. Castelbaum, A. J. et al. Characterization of integrin expression in a well differentiated endometrial adenocarcinoma cell line (Ishikawa). J. Clin. Endocrinol. Metab. 82, 136-142 (1997).
22. Peng, C., Rich, E. D. & Varnum, M. D. Achromatopsia-associated mutation in the human cone photoreceptor cyclic nucleotide-gated channel CNGB3 subunit alters the ligand sensitivity and pore properties of heteromeric channels. J. Biol. Chem. 278, 34533-34540 (2003).
23. del Rio, G., Castro-Obregon, S., Rao, R., Ellerby, H. M. & Bredesen, D. E. APAP, a sequence-pattern recognition approach identifies substance P as a potential apoptotic peptide. FEBS Lett. 494, 213-219 (2001).
24. Ellerby, H. M. et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 5, 1032-1038 (1999).
25. Gerlag, D. M. et al. Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res. 3, 357-361 (2001).
26. Midoux, P., LeCam, E., Coulaud, D., Delain, E. & Pichon, C. Histidine containing peptides and polypeptides as nucleic acid vectors. Somat. Cell Mol. Genet. 27, 27-47 (2002).
27. Pichon, C., Goncalves, C. & Midoux, P. Histidine-rich peptides and polymers for nucleic acids delivery. Adv. Drug Deliv. Rev. 53, 75-94 (2001).
28. Dmowski, W. P. et al. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum. Reprod. 16, 1802-1808 (2001).
29. Beliard, A., Noel, A. & Foidart, J. M. Reduction of apoptosis and proliferation in endometriosis. Fertil. Steril. 82, 80-85 (2004).
30. Ruoslahti, E. Drug targeting to specific vascular sites. Drug Discov. Today 7, 1138-1143 (2002).
31. Laakkonen, P. et al. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc. Natl Acad. Sci. USA 101, 9381-9386 (2004).
32. Oku, N. et al. Anti-neovascular therapy using novel peptides homing to angiogenic vessels. Oncogene 21, 2662-2669 (2002).
33. Fukuda, M. N. et al. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res. 60, 450-456 (2000).
34. Sugihara, K. et al. Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation. Proc. Natl Acad. Sci. USA 104, 3799-3804 (2007).
35. Jones, M. K., Anantharamaiah, G. M. & Segrest, J. P. Computer programs to identify and classify amphipathic alpha helical domains. J. Lipid Res. 33, 287-296 (1992).
36. Martin, M. E. & Rice, K. G. Peptide-guided gene delivery. AAPS J. 9, E18-E29 (2007).
37. Hoffman, J. A., Laakkonen, P., Porkka, K. & Ruoslahti, E. Phage Display: A Practical Approach (Oxford Univ. Press, 2002).
38. Boyle, D. P. & McCluggage, W. G. Peritoneal stromal endometriosis: a detailed morphological analysis of a large series of cases of a common and under-recognised form of endometriosis. J. Clin. Pathol. 62, 530-533 (2009).
39. Okada, A. et al. Functional role of hCngb3 in regulation of human cone cng channel: effect of rod monochromacy-associated mutations in hCNGB3 on channel function. Invest. Ophthalmol. Vis. Sci. 45, 2324-2332 (2004).
40. Aplin, J. D., Hey, N. A. & Graham, R. A. Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity. Glycobiology 8, 269-276 (1998).
41. Nisolle, M., Casanas-Roux, F. & Donnez, J. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil. Steril. 68, 912-919 (1997).